Allurion Technologies Inc. - SIC # 7299 - MISCELLANEOUS PERSONAL SERVICES, NOT ELSEWHERE CLASSIFIED

Ticker Exchange SIC # Website Latest Ticker
ALUR New York 7299 www.allurion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allurion Technologies Inc.

Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results - Jan 12th, 2026 6:30 am
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence - Nov 25th, 2025 7:25 am
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone - Nov 20th, 2025 7:00 am
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss - Nov 18th, 2025 7:00 am
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion - Nov 18th, 2025 2:01 am
4 Medical Product Stocks to Watch From a Challenging Industry - Nov 17th, 2025 7:20 am
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ... - Nov 12th, 2025 2:04 pm
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 12th, 2025 6:00 am
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing - Nov 11th, 2025 6:45 am
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025 - Nov 6th, 2025 2:05 pm
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss - Oct 7th, 2025 6:00 am
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference - Sep 30th, 2025 2:05 pm
Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates - Aug 19th, 2025 4:40 pm
Allurion Technologies Inc (ALUR) Q2 2025 Earnings Call Highlights: Strategic Pivot and Cost ... - Aug 14th, 2025 1:08 am
Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update - Aug 13th, 2025 6:00 am
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2 - Aug 7th, 2025 3:20 pm
Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025 - Aug 7th, 2025 2:05 pm
Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry - Aug 5th, 2025 6:00 am
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates - Aug 1st, 2025 3:15 pm
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates - Jul 31st, 2025 3:35 pm